COVID19
Clinical trials for COVID19 explained in plain language.
Never miss a new study
Get alerted when new COVID19 trials appear
Sign up with your email to follow new studies for COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
COVID drug study in kids halted after only 6 patients
Disease control TerminatedThis study aimed to see if baricitinib, a drug used for COVID-19 in adults, is safe and works well in children aged 1 to 17 who were hospitalized with COVID-19 and needed extra oxygen. Only 6 children took part before the study was stopped early. The main goals were to measure ho…
Matched conditions: COVID19
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
Stem cell shot for COVID lung failure shows early promise
Disease control TerminatedThis study tested whether a single infusion of stem cells from donated umbilical cord tissue could help hospitalized adults with severe COVID-19 avoid breathing machines or death. Nineteen participants received either the stem cells or a placebo, plus standard care. The trial was…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental antibody for severe COVID-19 falls short as trial ends early
Disease control TerminatedThis study tested an experimental antibody called SCTA01 in hospitalized adults with severe COVID-19. The goal was to see if it could speed up recovery compared to a placebo. The trial was stopped early after enrolling 102 participants, so the results are limited.
Matched conditions: COVID19
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Ancient herbal remedy put to the test against COVID-19
Symptom relief TerminatedThis small pilot study tested whether a traditional Chinese medicine called Xuanfei Baidu granules is safe and acceptable for people with mild to moderate COVID-19. Only 10 participants were enrolled before the study was stopped early. The main goal was to see how many people wou…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: Darcy Spicer • Aim: Symptom relief
Last updated May 17, 2026 07:05 UTC
-
Smart vest tracks COVID-19 trends in hospital patients
Knowledge-focused TerminatedThis study tested a special wearable vest that collects health data from people hospitalized with COVID-19. The goal was to see if the vest could track changes in the disease over time. About 15 adults took part, but the study was stopped early.
Matched conditions: COVID19
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Arthritis drugs may alter COVID-19 immune response, study finds
Knowledge-focused TerminatedThis study looked at whether immunosuppressive medications used for rheumatoid arthritis or spondyloarthritis change how the body handles a COVID-19 infection. Researchers compared 150 patients on these drugs with infected family members not on such treatments. The goal was to me…
Matched conditions: COVID19
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC
-
New brain scanner peers into COVID's neurological mysteries
Knowledge-focused TerminatedThis study tested a new brain imaging device that combines PET and MRI scans to look at brain function and structure in people who have had COVID-19 and those who haven't. The goal was to see if the device works well and to develop a standard way to use it for future research. On…
Matched conditions: COVID19
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
Eye scans reveal hidden COVID-19 damage?
Knowledge-focused TerminatedThis study aimed to collect eye scans from people who had COVID-19 to see if the virus caused damage to the retina, the light-sensitive part of the eye. Researchers compared patients who had severe COVID-19 with those who had mild cases. The study was stopped early and included 2…
Matched conditions: COVID19
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC